Trial intelligence / Profile preview

Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients

NCT01384994Phase 2Unknown

Sponsor
Volker Heinemann
Start
Aug 2011
Primary completion
Aug 2013
Modality
Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
Countries
1
01

Overview

A Phase 2 trial of panitumumab in colorectal cancer (CRC), sponsored by Volker Heinemann. Status: unknown.

02

Drugs

panitumumab
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT01384994.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01384994.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call